Back to companies
Beam Therapeutics Inc.
BEAMUSNASDAQPharmaceuticals & HealthcareBeam Therapeutics Inc.
Revenue
$139.7mn
YoY +120.0%
Operating income
-$383.7mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API